| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Nephropathies | 29 | 2019 | 972 | 1.830 |
Why?
|
| Diabetes Mellitus, Type 1 | 27 | 2024 | 3416 | 1.510 |
Why?
|
| Metformin | 5 | 2020 | 906 | 1.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 17 | 2020 | 12145 | 1.140 |
Why?
|
| C-Peptide | 2 | 2019 | 441 | 1.050 |
Why?
|
| Calcium Channel Blockers | 3 | 2018 | 694 | 1.030 |
Why?
|
| Hypoglycemic Agents | 9 | 2024 | 3086 | 1.010 |
Why?
|
| Cations, Divalent | 1 | 2024 | 167 | 0.930 |
Why?
|
| Insulin | 16 | 2017 | 6588 | 0.920 |
Why?
|
| Diabetes Mellitus | 9 | 2022 | 5841 | 0.910 |
Why?
|
| Renal Insufficiency, Chronic | 7 | 2020 | 2254 | 0.890 |
Why?
|
| Leishmaniasis | 17 | 1990 | 67 | 0.860 |
Why?
|
| Kidney Transplantation | 11 | 2021 | 4240 | 0.800 |
Why?
|
| Kidney Failure, Chronic | 15 | 2021 | 2478 | 0.790 |
Why?
|
| Organ Transplantation | 4 | 2020 | 1164 | 0.770 |
Why?
|
| Altitude | 1 | 2022 | 163 | 0.730 |
Why?
|
| Blood Glucose | 12 | 2020 | 6390 | 0.720 |
Why?
|
| Heart Transplantation | 3 | 2020 | 3258 | 0.710 |
Why?
|
| Heart Failure | 13 | 2022 | 11701 | 0.680 |
Why?
|
| Cardiovascular Diseases | 14 | 2020 | 15513 | 0.670 |
Why?
|
| Calcium Channels | 2 | 2023 | 620 | 0.630 |
Why?
|
| Insulin, Long-Acting | 1 | 2017 | 58 | 0.570 |
Why?
|
| Hypertension | 10 | 2018 | 8537 | 0.560 |
Why?
|
| Renal Dialysis | 13 | 2018 | 1796 | 0.550 |
Why?
|
| Angina Pectoris | 4 | 2019 | 959 | 0.530 |
Why?
|
| Host-Pathogen Interactions | 1 | 2024 | 1448 | 0.510 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2024 | 1913 | 0.500 |
Why?
|
| Dehydration | 1 | 2017 | 216 | 0.500 |
Why?
|
| Acidosis, Lactic | 1 | 2017 | 146 | 0.500 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 794 | 0.480 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2023 | 934 | 0.480 |
Why?
|
| Autonomic Nervous System | 5 | 2006 | 704 | 0.480 |
Why?
|
| Fibrinogen | 3 | 2013 | 888 | 0.470 |
Why?
|
| Fumarates | 2 | 2016 | 131 | 0.450 |
Why?
|
| Pharmacists | 1 | 2016 | 259 | 0.450 |
Why?
|
| Diabetic Angiopathies | 6 | 2019 | 805 | 0.440 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 858 | 0.420 |
Why?
|
| Hematinics | 3 | 2015 | 282 | 0.410 |
Why?
|
| Kidney | 5 | 2022 | 7034 | 0.410 |
Why?
|
| Hemofiltration | 1 | 2012 | 59 | 0.400 |
Why?
|
| Kidney Diseases | 3 | 2019 | 2092 | 0.400 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 585 | 0.400 |
Why?
|
| Quinolines | 1 | 2018 | 764 | 0.400 |
Why?
|
| Renal Insufficiency | 3 | 2016 | 808 | 0.400 |
Why?
|
| Amides | 2 | 2016 | 449 | 0.390 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2006 | 854 | 0.380 |
Why?
|
| Antihypertensive Agents | 3 | 2016 | 2019 | 0.380 |
Why?
|
| Hypolipidemic Agents | 1 | 2015 | 609 | 0.370 |
Why?
|
| Proteinuria | 3 | 2007 | 604 | 0.370 |
Why?
|
| Erythropoietin | 3 | 2015 | 719 | 0.360 |
Why?
|
| Humans | 144 | 2024 | 761098 | 0.360 |
Why?
|
| Hospitals, Special | 1 | 2011 | 91 | 0.360 |
Why?
|
| Mass Screening | 3 | 2016 | 5425 | 0.360 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1936 | 0.350 |
Why?
|
| Oxygen | 1 | 2022 | 4226 | 0.350 |
Why?
|
| Coronary Vasospasm | 1 | 2010 | 81 | 0.350 |
Why?
|
| Communicable Diseases | 1 | 2018 | 873 | 0.340 |
Why?
|
| Medicine | 1 | 2018 | 942 | 0.330 |
Why?
|
| Watchful Waiting | 1 | 2013 | 489 | 0.330 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 320 | 0.320 |
Why?
|
| Mitral Valve | 3 | 2013 | 1465 | 0.310 |
Why?
|
| Hypercholesterolemia | 1 | 2015 | 1141 | 0.310 |
Why?
|
| Heart Diseases | 4 | 2018 | 2795 | 0.300 |
Why?
|
| Ketoconazole | 5 | 1987 | 97 | 0.290 |
Why?
|
| Cholesterol | 2 | 2015 | 2902 | 0.280 |
Why?
|
| Sepsis | 2 | 2018 | 2586 | 0.280 |
Why?
|
| Glomerular Filtration Rate | 5 | 2019 | 2181 | 0.270 |
Why?
|
| Renin | 2 | 2016 | 639 | 0.270 |
Why?
|
| Air Pollution | 1 | 2020 | 2351 | 0.270 |
Why?
|
| Paromomycin | 4 | 1993 | 14 | 0.260 |
Why?
|
| Athletes | 1 | 2014 | 1138 | 0.260 |
Why?
|
| Smoking | 3 | 2018 | 9055 | 0.260 |
Why?
|
| Anemia | 3 | 2016 | 1504 | 0.260 |
Why?
|
| Hemodynamics | 6 | 2012 | 4164 | 0.260 |
Why?
|
| Terminal Care | 1 | 2018 | 1755 | 0.260 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3245 | 0.250 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1559 | 0.250 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2013 | 1400 | 0.250 |
Why?
|
| Autonomic Nervous System Diseases | 5 | 1999 | 268 | 0.250 |
Why?
|
| Schools | 1 | 2014 | 1483 | 0.240 |
Why?
|
| Calcium | 3 | 2024 | 5720 | 0.240 |
Why?
|
| Enalapril | 1 | 2016 | 310 | 0.230 |
Why?
|
| Heart Rate | 10 | 2017 | 4196 | 0.230 |
Why?
|
| Students | 1 | 2014 | 1737 | 0.220 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 2642 | 0.220 |
Why?
|
| Stroke | 6 | 2019 | 9720 | 0.220 |
Why?
|
| Renal Artery Obstruction | 1 | 2004 | 218 | 0.210 |
Why?
|
| Hemorrhage | 1 | 2015 | 3422 | 0.210 |
Why?
|
| Glucagon-Like Peptides | 1 | 2024 | 153 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2018 | 3405 | 0.200 |
Why?
|
| Cation Transport Proteins | 1 | 2024 | 326 | 0.190 |
Why?
|
| Diabetic Retinopathy | 4 | 2010 | 1274 | 0.190 |
Why?
|
| Heart Failure, Systolic | 1 | 2013 | 135 | 0.190 |
Why?
|
| Male | 79 | 2019 | 360675 | 0.190 |
Why?
|
| Gram-Negative Bacteria | 1 | 2023 | 271 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3821 | 0.180 |
Why?
|
| Diabetic Neuropathies | 4 | 1999 | 406 | 0.180 |
Why?
|
| Coronary Disease | 6 | 2004 | 5921 | 0.180 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 529 | 0.180 |
Why?
|
| Cardiovascular System | 1 | 2007 | 836 | 0.170 |
Why?
|
| Neoplasms | 3 | 2018 | 22125 | 0.160 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1504 | 0.160 |
Why?
|
| Coronary Vessels | 2 | 2010 | 3111 | 0.160 |
Why?
|
| Infusions, Intravenous | 5 | 2010 | 2217 | 0.160 |
Why?
|
| Female | 73 | 2019 | 392458 | 0.160 |
Why?
|
| Aged | 36 | 2019 | 169266 | 0.160 |
Why?
|
| Registries | 1 | 2015 | 8236 | 0.160 |
Why?
|
| Benzethonium | 3 | 1987 | 6 | 0.160 |
Why?
|
| Sulfonylurea Compounds | 1 | 2020 | 219 | 0.160 |
Why?
|
| Postoperative Complications | 3 | 2017 | 15634 | 0.150 |
Why?
|
| Chest Pain | 2 | 2010 | 1095 | 0.150 |
Why?
|
| Esophageal Diseases | 1 | 1999 | 168 | 0.150 |
Why?
|
| Middle Aged | 54 | 2019 | 220835 | 0.150 |
Why?
|
| Fertilization | 1 | 2018 | 198 | 0.140 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 1987 | 202 | 0.140 |
Why?
|
| Phosphorus | 1 | 2018 | 332 | 0.140 |
Why?
|
| Drug Therapy, Combination | 7 | 2016 | 6305 | 0.140 |
Why?
|
| Glucuronidase | 1 | 2018 | 202 | 0.140 |
Why?
|
| Blood Viscosity | 1 | 1997 | 124 | 0.140 |
Why?
|
| Insulin Infusion Systems | 2 | 2017 | 217 | 0.140 |
Why?
|
| Atrial Fibrillation | 2 | 2015 | 5115 | 0.130 |
Why?
|
| Balneology | 1 | 1996 | 2 | 0.130 |
Why?
|
| Cholesterol, LDL | 4 | 2020 | 2380 | 0.130 |
Why?
|
| Leishmania mexicana | 2 | 1993 | 33 | 0.130 |
Why?
|
| Fibrinolysis | 1 | 1997 | 332 | 0.130 |
Why?
|
| Psoriasis | 3 | 1996 | 945 | 0.130 |
Why?
|
| Drug Resistance, Microbial | 1 | 2018 | 826 | 0.120 |
Why?
|
| Disease Progression | 8 | 2010 | 13506 | 0.120 |
Why?
|
| Motion Therapy, Continuous Passive | 1 | 2014 | 11 | 0.120 |
Why?
|
| Acute Kidney Injury | 8 | 1982 | 1923 | 0.120 |
Why?
|
| Antitubercular Agents | 1 | 2023 | 1375 | 0.120 |
Why?
|
| Diabetes Complications | 4 | 2005 | 1315 | 0.120 |
Why?
|
| Adult | 53 | 2019 | 221083 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2017 | 1242 | 0.110 |
Why?
|
| Hematoma | 1 | 1999 | 763 | 0.110 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2018 | 497 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 989 | 0.110 |
Why?
|
| Patient Advocacy | 1 | 1995 | 359 | 0.110 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 1178 | 0.110 |
Why?
|
| Risk Factors | 11 | 2019 | 74219 | 0.110 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1992 | 63 | 0.110 |
Why?
|
| Coronary Angiography | 7 | 2010 | 4506 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 7405 | 0.100 |
Why?
|
| Cause of Death | 3 | 2019 | 3688 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 863 | 0.100 |
Why?
|
| Angina Pectoris, Variant | 2 | 2010 | 53 | 0.100 |
Why?
|
| Heart | 3 | 2022 | 4431 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 575 | 0.100 |
Why?
|
| Health Care Rationing | 1 | 1995 | 435 | 0.100 |
Why?
|
| Australia | 1 | 2016 | 1246 | 0.100 |
Why?
|
| North America | 1 | 2016 | 1281 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 2 | 2006 | 143 | 0.100 |
Why?
|
| Prognosis | 7 | 2019 | 29672 | 0.100 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 1803 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2024 | 2015 | 0.090 |
Why?
|
| Follow-Up Studies | 13 | 2016 | 39121 | 0.090 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 1993 | 136 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2016 | 6482 | 0.090 |
Why?
|
| Erythromycin Ethylsuccinate | 1 | 1990 | 2 | 0.090 |
Why?
|
| Muscle Tonus | 1 | 2010 | 82 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2011 | 1116 | 0.090 |
Why?
|
| Ethics, Medical | 1 | 1995 | 786 | 0.090 |
Why?
|
| Leishmaniasis, Mucocutaneous | 1 | 1989 | 14 | 0.090 |
Why?
|
| Hospital Units | 1 | 2011 | 142 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2018 | 2247 | 0.090 |
Why?
|
| Creatinine | 5 | 1998 | 1897 | 0.090 |
Why?
|
| Risk | 6 | 2018 | 9614 | 0.090 |
Why?
|
| Rifampin | 4 | 1987 | 338 | 0.090 |
Why?
|
| Renal Replacement Therapy | 1 | 2012 | 281 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 1111 | 0.080 |
Why?
|
| Lupus Vulgaris | 1 | 1989 | 10 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 26068 | 0.080 |
Why?
|
| Self Care | 1 | 2014 | 795 | 0.080 |
Why?
|
| Europe | 1 | 2016 | 3422 | 0.080 |
Why?
|
| Double-Blind Method | 4 | 2016 | 12341 | 0.080 |
Why?
|
| Pemphigus | 3 | 1991 | 107 | 0.080 |
Why?
|
| Glucosides | 1 | 2013 | 512 | 0.080 |
Why?
|
| Uracil | 1 | 1990 | 207 | 0.080 |
Why?
|
| Periodicity | 1 | 2010 | 347 | 0.080 |
Why?
|
| Valsalva Maneuver | 3 | 1998 | 99 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2016 | 883 | 0.080 |
Why?
|
| Contrast Media | 6 | 1991 | 5311 | 0.080 |
Why?
|
| Treatment Failure | 2 | 2016 | 2643 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 1 | 2014 | 625 | 0.080 |
Why?
|
| Heart Block | 1 | 1990 | 385 | 0.080 |
Why?
|
| Triazoles | 1 | 2013 | 903 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58946 | 0.070 |
Why?
|
| Vasoconstriction | 1 | 2010 | 592 | 0.070 |
Why?
|
| Certification | 1 | 2011 | 418 | 0.070 |
Why?
|
| Thromboembolism | 2 | 2013 | 993 | 0.070 |
Why?
|
| Pyrazines | 1 | 2013 | 1202 | 0.070 |
Why?
|
| Electrocardiography, Ambulatory | 5 | 1999 | 577 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 4189 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2021 | 41486 | 0.070 |
Why?
|
| Dapsone | 1 | 1987 | 56 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2018 | 10083 | 0.070 |
Why?
|
| Angiography | 4 | 1982 | 1597 | 0.070 |
Why?
|
| Chondroblastoma | 1 | 1987 | 47 | 0.070 |
Why?
|
| Benzhydryl Compounds | 1 | 2013 | 917 | 0.070 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 1986 | 42 | 0.070 |
Why?
|
| Lithium | 2 | 1991 | 596 | 0.070 |
Why?
|
| Health Expenditures | 1 | 2019 | 2363 | 0.070 |
Why?
|
| Uremia | 4 | 1984 | 202 | 0.060 |
Why?
|
| Echocardiography | 4 | 1992 | 5006 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2014 | 983 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5494 | 0.060 |
Why?
|
| Bacteria | 1 | 2017 | 2190 | 0.060 |
Why?
|
| Prospective Studies | 14 | 2014 | 54419 | 0.060 |
Why?
|
| Models, Biological | 1 | 2022 | 9455 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2018 | 3183 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2013 | 1525 | 0.060 |
Why?
|
| Kidney Function Tests | 2 | 2005 | 680 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2009 | 8639 | 0.060 |
Why?
|
| Skin Transplantation | 5 | 1983 | 1091 | 0.060 |
Why?
|
| Vitamin D | 1 | 2018 | 3302 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2012 | 3951 | 0.060 |
Why?
|
| Penicillins | 1 | 1987 | 403 | 0.060 |
Why?
|
| Miconazole | 1 | 1984 | 9 | 0.060 |
Why?
|
| Verapamil | 1 | 1984 | 242 | 0.060 |
Why?
|
| Animals | 8 | 2024 | 168083 | 0.060 |
Why?
|
| Elephantiasis | 1 | 1983 | 11 | 0.060 |
Why?
|
| Obesity | 4 | 2016 | 12937 | 0.060 |
Why?
|
| Lymphogranuloma Venereum | 1 | 1983 | 14 | 0.060 |
Why?
|
| Electrocardiography | 6 | 2006 | 6385 | 0.060 |
Why?
|
| Clotrimazole | 1 | 1984 | 76 | 0.060 |
Why?
|
| Peritoneal Dialysis | 2 | 1988 | 159 | 0.060 |
Why?
|
| Hypertension, Renovascular | 1 | 2004 | 115 | 0.060 |
Why?
|
| Administration, Topical | 5 | 1993 | 703 | 0.060 |
Why?
|
| Circadian Rhythm | 4 | 1999 | 2570 | 0.060 |
Why?
|
| Amphotericin B | 1 | 1984 | 142 | 0.050 |
Why?
|
| Sympathetic Nervous System | 2 | 2014 | 519 | 0.050 |
Why?
|
| United States | 3 | 2021 | 72337 | 0.050 |
Why?
|
| Pancreatic Pseudocyst | 1 | 1983 | 111 | 0.050 |
Why?
|
| Hospitalization | 1 | 2013 | 10712 | 0.050 |
Why?
|
| Metolazone | 1 | 1982 | 3 | 0.050 |
Why?
|
| Israel | 2 | 2014 | 718 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12058 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 1984 | 175 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 1986 | 505 | 0.050 |
Why?
|
| Genital Diseases, Female | 1 | 1983 | 192 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 1984 | 293 | 0.050 |
Why?
|
| Belize | 2 | 1993 | 15 | 0.050 |
Why?
|
| Diuretics | 2 | 1982 | 611 | 0.050 |
Why?
|
| Polyarteritis Nodosa | 1 | 1982 | 70 | 0.050 |
Why?
|
| Graft Survival | 1 | 1992 | 3841 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14607 | 0.050 |
Why?
|
| Hemostasis | 2 | 2005 | 470 | 0.050 |
Why?
|
| Calcinosis | 1 | 1990 | 1477 | 0.050 |
Why?
|
| Stroke Volume | 3 | 2016 | 5520 | 0.050 |
Why?
|
| Factor VII | 1 | 2001 | 139 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11856 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 1812 | 0.040 |
Why?
|
| Aortic Valve | 1 | 1990 | 1959 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 1983 | 367 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 1874 | 0.040 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2004 | 244 | 0.040 |
Why?
|
| Amyloid | 1 | 1984 | 848 | 0.040 |
Why?
|
| Phentermine | 1 | 1998 | 31 | 0.040 |
Why?
|
| Transplantation, Homologous | 5 | 1995 | 4822 | 0.040 |
Why?
|
| Fenfluramine | 1 | 1998 | 58 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 30006 | 0.040 |
Why?
|
| Hand | 2 | 1983 | 902 | 0.040 |
Why?
|
| Appetite Depressants | 1 | 1998 | 108 | 0.040 |
Why?
|
| Imidazoles | 1 | 1984 | 1173 | 0.040 |
Why?
|
| Rheumatic Fever | 1 | 1977 | 73 | 0.040 |
Why?
|
| Drainage | 1 | 1983 | 1158 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2010 | 5971 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 1999 | 366 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2011 | 5296 | 0.030 |
Why?
|
| Lymphedema | 1 | 1983 | 523 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2018 | 64670 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2005 | 8478 | 0.030 |
Why?
|
| Skin Neoplasms | 3 | 1987 | 5809 | 0.030 |
Why?
|
| Heart Valve Diseases | 2 | 1990 | 1030 | 0.030 |
Why?
|
| Amyloidosis | 1 | 1984 | 864 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2013 | 769 | 0.030 |
Why?
|
| Oceans and Seas | 1 | 1996 | 47 | 0.030 |
Why?
|
| Jordan | 1 | 1996 | 73 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2011 | 4319 | 0.030 |
Why?
|
| Acne Vulgaris | 1 | 1981 | 349 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80673 | 0.030 |
Why?
|
| Mitral Valve Stenosis | 1 | 1977 | 341 | 0.030 |
Why?
|
| Adolescent | 8 | 2018 | 88271 | 0.030 |
Why?
|
| Leptin | 2 | 2014 | 1595 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2016 | 9317 | 0.030 |
Why?
|
| Survival Rate | 3 | 1995 | 12727 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2009 | 22157 | 0.030 |
Why?
|
| Posture | 2 | 1998 | 956 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 1987 | 2527 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1998 | 576 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 11475 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2014 | 249 | 0.030 |
Why?
|
| Drug Hypersensitivity | 1 | 1982 | 918 | 0.030 |
Why?
|
| Agglutination Tests | 1 | 1993 | 41 | 0.030 |
Why?
|
| Isoniazid | 2 | 1987 | 283 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1995 | 776 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 2130 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 1992 | 223 | 0.020 |
Why?
|
| Resistin | 1 | 2012 | 172 | 0.020 |
Why?
|
| Organogold Compounds | 1 | 1991 | 4 | 0.020 |
Why?
|
| Albuminuria | 1 | 2015 | 656 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1977 | 1281 | 0.020 |
Why?
|
| Triglycerides | 2 | 2015 | 2457 | 0.020 |
Why?
|
| Sex Factors | 1 | 2005 | 10552 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 1992 | 317 | 0.020 |
Why?
|
| Heart Ventricles | 3 | 2004 | 3812 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 1993 | 316 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1992 | 606 | 0.020 |
Why?
|
| Leishmania braziliensis | 1 | 1989 | 16 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1992 | 537 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1996 | 1664 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 1993 | 6198 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1992 | 831 | 0.020 |
Why?
|
| Aldosterone | 1 | 2014 | 869 | 0.020 |
Why?
|
| Ventricular Function, Left | 2 | 1992 | 3899 | 0.020 |
Why?
|
| Ointments | 2 | 1985 | 58 | 0.020 |
Why?
|
| Sulfates | 1 | 1990 | 378 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 1992 | 540 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2013 | 3268 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2855 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1992 | 1516 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 12467 | 0.020 |
Why?
|
| Mycobacterium bovis | 1 | 1989 | 146 | 0.020 |
Why?
|
| Podocytes | 1 | 2012 | 398 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6224 | 0.020 |
Why?
|
| Diatrizoate | 2 | 1978 | 81 | 0.020 |
Why?
|
| Alopecia Areata | 1 | 1990 | 128 | 0.020 |
Why?
|
| Home Care Services | 1 | 2014 | 647 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1987 | 51 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1993 | 1331 | 0.020 |
Why?
|
| Ampicillin | 1 | 1987 | 136 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 1995 | 1401 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2896 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1990 | 660 | 0.020 |
Why?
|
| Arthritis, Psoriatic | 1 | 1990 | 219 | 0.020 |
Why?
|
| Drug Combinations | 2 | 1998 | 2048 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1983 | 4021 | 0.020 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1987 | 74 | 0.020 |
Why?
|
| Urography | 2 | 1979 | 316 | 0.020 |
Why?
|
| Adiponectin | 1 | 2012 | 1106 | 0.020 |
Why?
|
| Amoxicillin | 1 | 1987 | 181 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3509 | 0.020 |
Why?
|
| Cocaine | 1 | 1991 | 958 | 0.020 |
Why?
|
| Skin | 3 | 1991 | 4473 | 0.020 |
Why?
|
| Zinc | 1 | 1990 | 672 | 0.020 |
Why?
|
| Antiprotozoal Agents | 1 | 1986 | 94 | 0.020 |
Why?
|
| Cell Division | 1 | 1993 | 4451 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 897 | 0.020 |
Why?
|
| Cisplatin | 1 | 1991 | 1651 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1983 | 9278 | 0.010 |
Why?
|
| Phenytoin | 1 | 1985 | 190 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2014 | 3548 | 0.010 |
Why?
|
| Clitoris | 1 | 1983 | 35 | 0.010 |
Why?
|
| Mast Cells | 1 | 1991 | 1392 | 0.010 |
Why?
|
| Vulvar Diseases | 1 | 1983 | 64 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1992 | 2242 | 0.010 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1985 | 247 | 0.010 |
Why?
|
| Heart Septum | 1 | 2004 | 301 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 10755 | 0.010 |
Why?
|
| Ear, External | 1 | 1983 | 165 | 0.010 |
Why?
|
| Hyperglycemia | 2 | 2000 | 1375 | 0.010 |
Why?
|
| Cholecystitis | 1 | 1983 | 180 | 0.010 |
Why?
|
| Ulcer | 1 | 1983 | 204 | 0.010 |
Why?
|
| Time Factors | 5 | 2004 | 39953 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3450 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1376 | 0.010 |
Why?
|
| Lipids | 1 | 1993 | 3330 | 0.010 |
Why?
|
| Papillon-Lefevre Disease | 1 | 1981 | 4 | 0.010 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 1981 | 17 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1999 | 1490 | 0.010 |
Why?
|
| Pruritus | 1 | 1985 | 378 | 0.010 |
Why?
|
| Antirheumatic Agents | 1 | 1991 | 1366 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 1983 | 405 | 0.010 |
Why?
|
| Hypotension, Orthostatic | 1 | 1984 | 257 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1991 | 2270 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1984 | 444 | 0.010 |
Why?
|
| Groin | 1 | 1980 | 106 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 898 | 0.010 |
Why?
|
| Edema | 1 | 1984 | 765 | 0.010 |
Why?
|
| Mice | 4 | 1993 | 81324 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1982 | 408 | 0.010 |
Why?
|
| Blood Platelet Disorders | 1 | 2000 | 60 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1978 | 149 | 0.010 |
Why?
|
| Transplantation, Autologous | 2 | 1981 | 2112 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2000 | 422 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1878 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1978 | 79 | 0.010 |
Why?
|
| Ergonovine | 1 | 1977 | 14 | 0.010 |
Why?
|
| Prolapse | 1 | 1977 | 63 | 0.010 |
Why?
|
| Leg Injuries | 1 | 1979 | 179 | 0.010 |
Why?
|
| Nose Neoplasms | 1 | 1979 | 249 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24013 | 0.010 |
Why?
|
| Iothalamate Meglumine | 1 | 1977 | 9 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1984 | 1474 | 0.010 |
Why?
|
| Myxoma | 1 | 1977 | 114 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1985 | 1378 | 0.010 |
Why?
|
| Iodine | 1 | 1979 | 285 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 771 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15845 | 0.010 |
Why?
|
| Cadaver | 1 | 1980 | 1358 | 0.010 |
Why?
|
| Epinephrine | 1 | 2000 | 792 | 0.010 |
Why?
|
| Nose | 1 | 1979 | 521 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 677 | 0.010 |
Why?
|
| Sodium | 1 | 1981 | 1589 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7844 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1984 | 1312 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20600 | 0.010 |
Why?
|
| Recurrence | 2 | 1985 | 8456 | 0.010 |
Why?
|
| Microcirculation | 1 | 2000 | 1280 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1991 | 4414 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 1977 | 364 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3114 | 0.010 |
Why?
|
| Retina | 1 | 1984 | 2656 | 0.010 |
Why?
|
| Reoperation | 1 | 1983 | 4304 | 0.010 |
Why?
|
| Protein Binding | 1 | 1984 | 9300 | 0.010 |
Why?
|
| Collagen | 1 | 2000 | 2635 | 0.010 |
Why?
|
| Child | 4 | 1987 | 80134 | 0.010 |
Why?
|
| Zinc Sulfate | 1 | 1990 | 18 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 1990 | 97 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1991 | 697 | 0.010 |
Why?
|
| Family | 1 | 1980 | 3193 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 23415 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1984 | 5091 | 0.000 |
Why?
|
| Cell Count | 1 | 1991 | 1831 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1979 | 2021 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1993 | 3419 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15308 | 0.000 |
Why?
|
| Leishmania tropica | 1 | 1985 | 8 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1991 | 716 | 0.000 |
Why?
|
| Inflammation | 1 | 2005 | 10758 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1990 | 2340 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1990 | 1331 | 0.000 |
Why?
|
| Nausea | 1 | 1987 | 679 | 0.000 |
Why?
|
| Vomiting | 1 | 1987 | 651 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1991 | 1390 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1985 | 42217 | 0.000 |
Why?
|
| Pedigree | 1 | 1990 | 4537 | 0.000 |
Why?
|
| Age Factors | 1 | 1978 | 18385 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 1780 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 21357 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 20120 | 0.000 |
Why?
|
| Methods | 1 | 1979 | 1063 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1988 | 2769 | 0.000 |
Why?
|
| Neutrophils | 1 | 1990 | 3763 | 0.000 |
Why?
|
| Fracture Fixation | 1 | 1979 | 366 | 0.000 |
Why?
|
| Cardiomegaly | 1 | 1979 | 590 | 0.000 |
Why?
|
| Coronary Care Units | 1 | 1977 | 235 | 0.000 |
Why?
|
| Microsurgery | 1 | 1979 | 793 | 0.000 |
Why?
|
| Acute Disease | 1 | 1982 | 7240 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 8000 | 0.000 |
Why?
|